US FDA Mulls ‘Orange Book’ Listing For Device, REMS, Digital App Patents

Patent files and documents in cabinet in office. 3D rendered illustration.
US FDA is re-evaluating the types of patents listed in the 'Orange Book.' • Source: Shutterstock

More from Generics

More from Biosimilars & Generics